The effects of hormone therapy on cognition in breast cancer

scientific article published in September 2003

The effects of hormone therapy on cognition in breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JSBMB.2003.07.001
P698PubMed publication ID14623538

P50authorLesley FallowfieldQ23772391
P2093author name stringValerie Jenkins
Tony Howell
Valerie Shilling
P2507corrigendum / erratumCorrigendum to “The effects of hormone therapy on cognition in breast cancer” [J. Steroid Biochem. Mol. Biol. 86 (2003) 405–412]Q57937840
P433issue3-5
P304page(s)405-412
P577publication date2003-09-01
P1433published inThe Journal of Steroid Biochemistry and Molecular BiologyQ15708871
P1476titleThe effects of hormone therapy on cognition in breast cancer
P478volume86

Reverse relations

cites work (P2860)
Q48014012A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy
Q38747069Acute memory deficits in chemotherapy-treated adults.
Q36528154Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage
Q37585300Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments
Q57192800Cancer-related cognitive impairment in breast cancer survivors: An examination of conceptual and statistical cognitive domains using principal component analysis
Q48284056Changes in perceived attentional function in women following breast cancer surgery
Q28566058Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus
Q38088668Clearing the air: a review of our current understanding of "chemo fog".
Q35164117Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults
Q58606275Cognitive Effects of Aromatase and Possible Role in Memory Disorders
Q35660927Cognitive changes associated with endocrine therapy for breast cancer.
Q43730922Cognitive dysfunction in people with cancer
Q44859258Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls
Q37157773Cognitive functioning in breast cancer survivors: a controlled comparison
Q43484591Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors
Q42704792Decision-making impairments in breast cancer patients treated with tamoxifen
Q36932994Effect of endocrine therapy on quality of life and cognitive functions in patients with breast cancer
Q48334506Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.
Q53132333Efficacy and safety of aromatase inhibitors in early breast cancer.
Q38901804Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies.
Q36684067Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level
Q41442004Inhibition of oestrogen biosynthesis induces mild anxiety in C57BL/6J ovariectomized female mice
Q36458593Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
Q37782342Is Systemic Anti-Cancer Therapy Neurotoxic? Does Chemo Brain Exist? And Should We Rename It?
Q37061881Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by β Amyloid
Q35616166Long-term consequences of estrogens administered in midlife on female cognitive aging
Q37354647Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review
Q51888707Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models.
Q37139476Neuropsychological sequelae of non-central nervous system cancer and cancer therapy
Q45111650Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy
Q36436653Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK.
Q37309638Protective actions of sex steroid hormones in Alzheimer's disease
Q33570551Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer
Q47745329Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study.
Q46458007Self-reported cognitive impairment after breast cancer treatment in young women from the ELIPPSE40 cohort: the long-term impact of chemotherapy
Q39061531Sex-Dependent Regulation of Aromatase-Mediated Synaptic Plasticity in the Basolateral Amygdala.
Q44863330Short Introduction and History
Q46342146Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study
Q30959013Structure-function-behavior relationship in estrogen-induced synaptic plasticity
Q45924447Study of the cognitive effects of chemotherapy: considerations in selection of a control group.
Q21146752Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
Q39212333Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature.
Q44700581Tamoxifen disrupts consolidation and retrieval of morphine-associated contextual memory in male mice: interaction with estradiol.
Q38653422The Impact of Endocrine Therapy on Cognitive Functions of Breast Cancer Patients: A Systematic Review.
Q33636517The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen

Q57937840Corrigendum to “The effects of hormone therapy on cognition in breast cancer” [J. Steroid Biochem. Mol. Biol. 86 (2003) 405–412]main subjectP921

Search more.